Search hospitals > Pennsylvania > Abington
Abington Memorial Hospital
Claim this profileAbington, Pennsylvania 19001
Global Leader in Skin Cancer
Global Leader in Ovarian Cancer
Conducts research for Relapse
Conducts research for Stomach Cancer
Conducts research for Endometrial Cancer
304 reported clinical trials
9 medical researchers
Summary
Abington Memorial Hospital is a medical facility located in Abington, Pennsylvania. This center is recognized for care of Skin Cancer, Ovarian Cancer, Relapse, Stomach Cancer, Endometrial Cancer and other specialties. Abington Memorial Hospital is involved with conducting 304 clinical trials across 322 conditions. There are 9 research doctors associated with this hospital, such as Mark Shahin, MD, Russell J Schilder, MD, Steven J. Cohen, and Donald Haas.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Ovarian Cancer
Global LeaderStage IV
Stage I
Stage III
Top PIs
Mark Shahin, MDAsplundh Cancer Pavilion6 years of reported clinical research
Expert in Ovarian Cancer
Studies Skin Cancer
19 reported clinical trials
61 drugs studied
Russell J Schilder, MDThomas Jefferson University Hospital2 years of reported clinical research
Studies Ovarian Cancer
Studies Endometrioid Carcinoma
10 reported clinical trials
16 drugs studied
Steven J. CohenAsplundh Cancer Pavilion5 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
6 reported clinical trials
16 drugs studied
Donald HaasAbington Memorial Hospital3 years of reported clinical research
Studies Heart Failure
Studies Congestive Heart Failure
5 reported clinical trials
8 drugs studied
Clinical Trials running at Abington Memorial Hospital
Stroke
Ovarian Cancer
Testicular cancer
Heart Failure
Ovarian Tumors
Ovarian Choriocarcinoma
Ovarian Carcinoma
Pancreatic Cancer
Testicular Choriocarcinoma
Testicular Carcinoma
Anti-Coagulant + Anti-Platelet Therapy
for Stroke Prevention
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
Recruiting2 awards Phase 36 criteria
Apixaban vs Aspirin
for Stroke Prevention in Atrial Fibrillation After Brain Bleed
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
Recruiting1 award Phase 36 criteria
Milvexian
for Stroke
This trial is testing whether milvexian can help prevent another stroke in people who have already had one by stopping blood clots from forming. Milvexian may reduce the risk of stroke without significant bleeding.
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Abington Memorial Hospital?
Abington Memorial Hospital is a medical facility located in Abington, Pennsylvania. This center is recognized for care of Skin Cancer, Ovarian Cancer, Relapse, Stomach Cancer, Endometrial Cancer and other specialties. Abington Memorial Hospital is involved with conducting 304 clinical trials across 322 conditions. There are 9 research doctors associated with this hospital, such as Mark Shahin, MD, Russell J Schilder, MD, Steven J. Cohen, and Donald Haas.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.